Innovative solutions for improving health deterioration conditions
due to capillary blood flow impairment

FIR Medical (FIRM) is a digital-first, clinician assisted platform that helps people attain a better quality of life and achieve greater productivity by improving their health deterioration conditions due to capillary blood flow impairment. We are in the process of developing several innovative solutions,empowered by our proprietary and patented far-infrared (FIR) light emission/amplification technology. Upon completing clinical trials, we will go to market with in-clinic as well as at-home usage, both tightly integrated with digital monitoring and AI-led remedial actions, to deliver effective and persistent care for our users. Our mission is to help relieve more than a billion people around the world from their sufferings due to capillary blood flow impairment with our innovative FIR solutions.

FirmClear®

FirmClear® is our audiology solution which is a lightweight, wireless headset with noise canceling earmuffs. The embedded FirmFocus®, our proprietary and patented core technologies, are non-intrusive microdevices that can emit/amplify FIR at a safe temperature, precise wavelength, and optimal intensity. With pinpoint targeting inside the narrow sensory cavity, our FIR solutions thrive to deliver the most effective results for blood flow rejuvenation.

Digital Engagement

Tightly coupled with FirmClear® is the FirmApp digital engagement platform, which provides a closed-loop, holistic at-home experience for the user as well as the corresponding support team of caretakers/clinicians for in-clinic use cases.

The app manages FirmClear usage sessions while collecting a rich set of data via digital monitoring, standardized sensory tests, interactive cognitive/behavioral tests, and integrated AI/ML models to let both the user and caretaker/clinician gain insights into progress or any necessary remediation concerning the underlying health conditions.

Clinical Studies

FIRM’s R&D team, based in Taiwan, has done extensive medtech research re our FIR technology and has performed more than 30 months of clinical study (still ongoing) in collaboration with Dr. Wenhuei Liao, Director of Otology with 30+ years of clinical experience. To date, hundreds of patients have been treated by FirmClear®, in combination with conventional therapies, with very positive and encouraging results.

For Sudden Sensorineural Hearing Loss, the experimental group average recovery time is shorter and average hearing improvement level is significantly better than control group.

For Tinnitus

  • Over 50% of the patients in the FirmClear® experimental group achieved THI scores improvement of > 30 points (95% confidence interval).
  • None of the patients from the medicine-only (no FIR treatment) control group achieved > 30 points improvement.

Stay In Touch

If you are interested in our products and would like to receive our latest news, please fill out the form below.

Or contact us for any inquiries at info@firmedical.com.

Please enable JavaScript in your browser to complete this form.
Name